281 related articles for article (PubMed ID: 29708812)
1. Investigational drugs for the treatment of endometriosis, an update on recent developments.
Barra F; Scala C; Mais V; Guerriero S; Ferrero S
Expert Opin Investig Drugs; 2018 May; 27(5):445-458. PubMed ID: 29708812
[TBL] [Abstract][Full Text] [Related]
2. An overview of early drug development for endometriosis.
Leone Roberti Maggiore U; Ferrero S
Expert Opin Investig Drugs; 2016; 25(2):227-47. PubMed ID: 26619754
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments.
Barra F; Grandi G; Tantari M; Scala C; Facchinetti F; Ferrero S
Expert Opin Biol Ther; 2019 Apr; 19(4):343-360. PubMed ID: 30763525
[TBL] [Abstract][Full Text] [Related]
4. Current and Emerging Therapeutics for the Management of Endometriosis.
Ferrero S; Barra F; Leone Roberti Maggiore U
Drugs; 2018 Jul; 78(10):995-1012. PubMed ID: 29946962
[TBL] [Abstract][Full Text] [Related]
5. Current and emerging treatment options for endometriosis.
Ferrero S; Evangelisti G; Barra F
Expert Opin Pharmacother; 2018 Jul; 19(10):1109-1125. PubMed ID: 29975553
[TBL] [Abstract][Full Text] [Related]
6. Advances in pharmacotherapy for treating endometriosis.
Tafi E; Leone Roberti Maggiore U; Alessandri F; Bogliolo S; Gardella B; Vellone VG; Grillo F; Mastracci L; Ferrero S
Expert Opin Pharmacother; 2015; 16(16):2465-83. PubMed ID: 26569155
[TBL] [Abstract][Full Text] [Related]
7. Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain.
Barra F; Scala C; Ferrero S
Drugs Today (Barc); 2019 Apr; 55(4):237-246. PubMed ID: 31050692
[TBL] [Abstract][Full Text] [Related]
8. Overview of elagolix for the treatment of endometriosis.
Melis GB; Neri M; Corda V; Malune ME; Piras B; Pirarba S; Guerriero S; Orrù M; D'Alterio MN; Angioni S; Paoletti AM
Expert Opin Drug Metab Toxicol; 2016 May; 12(5):581-8. PubMed ID: 27021205
[TBL] [Abstract][Full Text] [Related]
9. Investigational drugs for endometriosis.
Chlouber RO; Olive DL; Pritts EA
Expert Opin Investig Drugs; 2006 Apr; 15(4):399-407. PubMed ID: 16548789
[TBL] [Abstract][Full Text] [Related]
10. Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature.
Alessandro P; Luigi N; Felice S; Maria PA; Benedetto MG; Stefano A
Arch Gynecol Obstet; 2017 Apr; 295(4):827-832. PubMed ID: 28255765
[TBL] [Abstract][Full Text] [Related]
11. Emerging drugs for endometriosis.
Fedele L; Berlanda N
Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of elagolix in the treatment of endometriosis.
Perricos A; Wenzl R
Expert Opin Pharmacother; 2017 Sep; 18(13):1391-1397. PubMed ID: 28737050
[TBL] [Abstract][Full Text] [Related]
13. Elagolix, a novel, orally bioavailable GnRH antagonist under investigation for the treatment of endometriosis-related pain.
Ezzati M; Carr BR
Womens Health (Lond); 2015 Jan; 11(1):19-28. PubMed ID: 25581052
[TBL] [Abstract][Full Text] [Related]
14. Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas.
Dababou S; Garzon S; Laganà AS; Ferrero S; Evangelisti G; Noventa M; D'Alterio MN; Palomba S; Uccella S; Franchi M; Barra F
Expert Opin Investig Drugs; 2021 Sep; 30(9):903-911. PubMed ID: 34278887
[TBL] [Abstract][Full Text] [Related]
15. A review of phase II and III drugs for the treatment and management of endometriosis.
Perrone U; Evangelisti G; Laganà AS; Bogliolo S; Ceccaroni M; Izzotti A; Gustavino C; Ferrero S; Barra F
Expert Opin Emerg Drugs; 2023 Dec; 28(4):333-351. PubMed ID: 38099328
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of endometriosis by aromatase inhibitors: efficacy and side effects].
Racine AC; Legrand E; Lefebvre-Lacoeuille C; Hoppe E; Catala L; Sentilhes L; Descamps P
Gynecol Obstet Fertil; 2010 May; 38(5):318-23. PubMed ID: 20430665
[TBL] [Abstract][Full Text] [Related]
17. The role of pharmacotherapy in the treatment of endometriosis across the lifespan.
Schwartz K; Llarena NC; Rehmer JM; Richards EG; Falcone T
Expert Opin Pharmacother; 2020 Jun; 21(8):893-903. PubMed ID: 32164462
[TBL] [Abstract][Full Text] [Related]
18. New trends for the medical treatment of endometriosis.
Rocha AL; Reis FM; Petraglia F
Expert Opin Investig Drugs; 2012 Jul; 21(7):905-19. PubMed ID: 22568855
[TBL] [Abstract][Full Text] [Related]
19. Elagolix for endometriosis: all that glitters is not gold.
Vercellini P; Viganò P; Barbara G; Buggio L; Somigliana E;
Hum Reprod; 2019 Feb; 34(2):193-199. PubMed ID: 30551159
[TBL] [Abstract][Full Text] [Related]
20. Role of medical treatment of endometriosis.
Martone S; Troìa L; Marcolongo P; Luisi S
Minerva Obstet Gynecol; 2021 Jun; 73(3):304-316. PubMed ID: 34008385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
